T78.05XD Anaphylactic reaction due to tree nuts and seeds, subsequent encounter

Name of the Condition

• Anaphylactic reaction due to tree nuts and seeds, subsequent encounter (ICD-10 Code: T78.05XD)

Summary

This code is used to document an anaphylactic reaction specifically triggered by tree nuts and seeds during a subsequent encounter. Anaphylaxis is a severe, potentially life-threatening allergic reaction that requires immediate medical attention. The code applies when the reaction is directly linked to exposure to tree nuts or seeds and meets clinical criteria for anaphylaxis, and the encounter is not the initial one.

Causes

Anaphylactic reactions due to tree nuts and seeds occur when the immune system overreacts to specific proteins in these foods. The reaction is mediated by immunoglobulin E (IgE) antibodies, which release histamine and other chemicals, leading to rapid onset of symptoms. Common tree nuts include almonds, walnuts, pecans, and cashews, while seeds may include sesame, sunflower, or pumpkin seeds.

Risk Factors

• Previous history of tree nut or seed allergy or anaphylaxis
• Family history of allergic conditions
• Asthma or other atopic diseases
• Exposure to tree nuts or seeds, including cross-contamination
• Delayed administration of epinephrine during prior reactions

Symptoms

• Rapid onset of hives, itching, or swelling (especially of the lips, tongue, or throat)
• Difficulty breathing, wheezing, or stridor
• Drop in blood pressure (hypotension) or dizziness
• Nausea, vomiting, or abdominal cramps
• Loss of consciousness or confusion

Diagnosis

Diagnosis is based on clinical presentation and patient history. Key criteria include acute onset of symptoms, involvement of the skin, respiratory, cardiovascular, or gastrointestinal systems, and a known or likely exposure to tree nuts or seeds. Laboratory tests, such as specific IgE or skin prick tests, may support the diagnosis but are not required for coding.

Treatment Options

• Immediate administration of epinephrine (first-line treatment)
• Antihistamines or corticosteroids to manage symptoms
• Oxygen therapy or respiratory support if needed
• Intravenous fluids for hypotension
• Monitoring in a medical setting for recurrence or progression

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and timeliness of treatment. Most patients recover with prompt care, but follow-up is essential to assess for delayed reactions or complications. Long-term management includes allergen avoidance, carrying an epinephrine auto-injector, and referral to an allergist for further evaluation.

Complications

• Respiratory failure or arrest
• Cardiovascular collapse
• Asphyxiation from airway swelling
• Biphasic reactions (recurrence of symptoms hours after initial treatment)
• Anxiety or post-traumatic stress related to the event

Lifestyle & Prevention

• Strict avoidance of tree nuts and seeds, including reading food labels for hidden ingredients
• Informing restaurants and caregivers about the allergy
• Carrying an epinephrine auto-injector at all times
• Wearing medical identification (e.g., bracelet) indicating the allergy
• Educating family and friends on recognizing and responding to anaphylaxis

When to Seek Professional Help

Seek immediate medical attention if symptoms of anaphylaxis occur, such as difficulty breathing, swelling of the throat, dizziness, or loss of consciousness. Even if symptoms improve after epinephrine, follow-up care is necessary to prevent recurrence or complications.

Tips for Medical Coders

This code is for a subsequent encounter, meaning it should be used when the patient is receiving care for the anaphylactic reaction after the initial episode. Documentation must confirm the reaction was due to tree nuts or seeds and that the encounter is not the first. Ensure the medical record specifies the allergen and the encounter type to support accurate coding.